Royal Philips (NYSE: PHG, AEX: PHIA), the Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) and Main-Taunus Cardiac Center (Bad Soden, Germany) today announced the results of a clinical study that demonstrate that the safety for patients and clinicians can be significantly enhanced during cardiac interventions. Using Philips’ recently introduced AlluraClarity system* with ClarityIQ technology, the doctors of the medical center were, for the first time, able to achieve a 50 percent reduction in X-ray dose while maintaining the excellent image quality needed during image-guided cardiac interventions.

Read more...

Agfa HealthCare will highlight its comprehensive IMPAX Cardiovascular suite of products at the EuroPCR congress, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), from May 21-24, in Paris, France. The focus will be on demonstrating how IMPAX Cardiovascular delivers the benefits of digital cardiology to the cardiologist's fingertips.

Read more...

EU Health Ministers, meeting in Dublin at the Ministerial eHealth High Level Conference organised jointly by the Irish Presidency of the Council of the European Union and the European Commission, today agreed a Declaration on eHealth presented by the Irish Presidency. The Declaration is aimed at prioritising the use of ICT in health among Member States to contribute to better, safer, sustainable and innovative healthcare systems for all European citizens.

Read more...

Agfa HealthCare's revenue remained almost stable versus last year's first quarter. Excluding currency effects, the business group posted a slight revenue increase. In the IT segment, both the Imaging IT business and the Enterprise IT business performed strongly. The segment posted strong growth figures in North America, Latin America and the North of Europe.

Read more...